PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Anebulo Pharmaceuticals, Inc. (ANEB)

Equity · Currency in USD · Last updated Nov 22, 2023
SummaryFinancials

Company Info

ISINUS0345691036
CUSIP034569103
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$55.11M
EPS-$0.46
Year Range$1.62 - $4.05
Target Price$6.50
Short %0.15%
Short Ratio0.22

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Anebulo Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-11.54%
7.57%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANEB

Anebulo Pharmaceuticals, Inc.

Return

Anebulo Pharmaceuticals, Inc. had a return of -11.29% year-to-date (YTD) and -18.56% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-11.29%18.20%
1 month-19.78%7.43%
6 months-11.52%9.47%
1 year-18.56%14.89%
5 years (annualized)N/A11.39%
10 years (annualized)N/A9.68%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20230.69%-22.60%3.98%-8.09%29.17%9.50%-27.99%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Anebulo Pharmaceuticals, Inc. (ANEB) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ANEB
Anebulo Pharmaceuticals, Inc.
-0.17
^GSPC
S&P 500
1.01

Sharpe Ratio

The current Anebulo Pharmaceuticals, Inc. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50JuneJulyAugustSeptemberOctoberNovember
-0.17
1.53
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Anebulo Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-75.98%
-7.52%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Anebulo Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Anebulo Pharmaceuticals, Inc. was 80.89%, occurring on Oct 16, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.89%May 24, 2021550Oct 16, 2023
-1.41%May 10, 20217May 18, 20211May 19, 20218

Volatility Chart

The current Anebulo Pharmaceuticals, Inc. volatility is 20.80%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%JuneJulyAugustSeptemberOctoberNovember
20.80%
4.24%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Recent discussions